CN Patent

CN115429748A — 一种泊沙康唑注射液的制备方法

Assigned to Jiangsu Aosaikang Pharmaceutical Co Ltd · Expires 2022-12-06 · 3y expired

What this patent protects

本发明提供了一种泊沙康唑注射液的制备方法，所述泊沙康唑注射液由泊沙康唑、磺丁基倍他环糊精钠、依地酸二钠、pH调节剂和水组成。

USPTO Abstract

本发明提供了一种泊沙康唑注射液的制备方法，所述泊沙康唑注射液由泊沙康唑、磺丁基倍他环糊精钠、依地酸二钠、pH调节剂和水组成。

Drugs covered by this patent

cysteine-hydrochloride (CYSTEINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN115429748A
Jurisdiction: CN
Classification: —
Expires: 2022-12-06
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Aosaikang Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.